Hippocampal sclerosis in Lewy body disease is a TDP-43 proteinopathy similar to FTLD-TDP Type A

Acta Neuropathologica

Volumn 129, Issue 1, 2015, Pages 53-64

  Aoki, Naoya ^a   Murray, Melissa E ^a   Ogaki, Kotaro ^a   Fujioka, Shinsuke ^a,b   Rutherford, Nicola J ^a,c   Rademakers, Rosa ^a   Ross, Owen A ^a   Dickson, Dennis W ^a  

^a MAYO GRADUATE SCHOOL   (United States)

^b FUKUOKA UNIVERSITY   (Japan)

^c UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

Hippocampal sclerosis; Lewy body disease; Neuropathology; TDP 43; TMEM106B

Indexed keywords

APOLIPOPROTEIN E4; DNA BINDING PROTEIN; GRN PROTEIN, HUMAN; MEMBRANE PROTEIN; NERVE PROTEIN; SIGNAL PEPTIDE; TDP-43 PROTEIN, HUMAN; TMEM106B PROTEIN, HUMAN;

AGED; FEMALE; FRONTOTEMPORAL LOBAR DEGENERATION; GENETICS; HIPPOCAMPUS; HUMAN; IMMUNOHISTOCHEMISTRY; LEWY BODY DISEASE; MALE; METABOLISM; NEURITE; PATHOLOGY; SCLEROSIS; TDP-43 PROTEINOPATHIES; VERY ELDERLY;

AGED; AGED, 80 AND OVER; APOLIPOPROTEIN E4; DNA-BINDING PROTEINS; FEMALE; FRONTOTEMPORAL LOBAR DEGENERATION; HIPPOCAMPUS; HUMANS; IMMUNOHISTOCHEMISTRY; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LEWY BODY DISEASE; MALE; MEMBRANE PROTEINS; NERVE TISSUE PROTEINS; NEURITES; SCLEROSIS; TDP-43 PROTEINOPATHIES;

EID: 84934335496     PISSN: 00016322     EISSN: 14320533     Source Type: Journal    
DOI: 10.1007/s00401-014-1358-z     Document Type: Article

References (32)

1. Ala TA, Beh GO, Frey WH 2nd (2000) Pure hippocampal sclerosis: a rare cause of dementia mimicking Alzheimer’s disease. Neurology 54:843–848
2. Amador-Ortiz C, Lin WL, Ahmed Z et al (2007) TDP-43 immunoreactivity in hippocampal sclerosis and Alzheimer’s disease. Ann Neurol 61:435–445
3. Arai T, Mackenzie IR, Hasegawa M et al (2009) Phosphorylated TDP-43 in Alzheimer’s disease and dementia with Lewy bodies. Acta Neuropathol 117:125–136
4. Braak H, Braak E (1991) Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 82:239–259
5. Dickson DW, Baker M, Rademakers R (2010) Common variant in GRN is a genetic risk factor for hippocampal sclerosis in the elderly. Neurodegener Dis 7:170–174
6. Dickson DW, Davies P, Bevona C et al (1994) Hippocampal sclerosis: a common pathological feature of dementia in very old (> or =80 years of age) humans. Acta Neuropathol 88:212–221
7. Finch N, Carrasquillo MM, Baker M et al (2011) TMEM106B regulates progranulin levels and the penetrance of FTLD in GRN mutation carriers. Neurology 76:467–474
8. Hatanpaa KJ, Bigio EH, Cairns NJ et al (2008) TAR DNA-binding protein 43 immunohistochemistry reveals extensive neuritic pathology in FTLD-U: a midwest-southwest consortium for FTLD study. J Neuropathol Exp Neurol 67:271–279
9. Higashi S, Iseki E, Yamamoto R et al (2007) Concurrence of TDP-43, tau and alpha-synuclein pathology in brains of Alzheimer’s disease and dementia with Lewy bodies. Brain Res 1184:284–294
10. Josephs KA, Ahmed Z, Katsuse O et al (2007) Neuropathologic features of frontotemporal lobar degeneration with ubiquitin-positive inclusions with progranulin gene (PGRN) mutations. J Neuropathol Exp Neurol 66:142–151
11. Josephs KA, Stroh A, Dugger B, Dickson DW (2009) Evaluation of subcortical pathology and clinical correlations in FTLD-U subtypes. Acta Neuropathol 118:349–358
12. Josephs KA, Whitwell JL, Weigand SD et al (2014) TDP-43 is a key player in the clinical features associated with Alzheimer’s disease. Acta Neuropathol 127:811–824
13. Kosaka K (2000) Diffuse Lewy body disease. Neuropathology 20(Suppl):S73–S78
14. Kosaka K (2014) Latest concept of Lewy body disease. Psychiatry Clin Neurosci 68:391–394
15. Lin WL, Castanedes-Casey M, Dickson DW (2009) Transactivation response DNA-binding protein 43 microvasculopathy in frontotemporal degeneration and familial Lewy body disease. J Neuropathol Exp Neurol 68:1167–1176
16. Mackenzie IR (2007) The neuropathology and clinical phenotype of FTD with progranulin mutations. Acta Neuropathol 114:49–54
17. Mackenzie IR, Baker M, Pickering-Brown S et al (2006) The neuropathology of frontotemporal lobar degeneration caused by mutations in the progranulin gene. Brain 129:3081–3090
18. Mackenzie IR, Neumann M, Baborie A et al (2011) A harmonized classification system for FTLD-TDP pathology. Acta Neuropathol 122:111–113
19. McKeith IG, Dickson DW, Lowe J et al (2005) Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium. Neurology 65:1863–1872
20. Murray ME, Bieniek KF, Banks Greenberg M et al (2013) Progressive amnestic dementia, hippocampal sclerosis, and mutation in C9ORF72. Acta Neuropathol 126:545–554
21. Murray ME, Cannon A, Graff-Radford NR et al (2014) Differential clinicopathologic and genetic features of late-onset amnestic dementias. Acta Neuropathol 128:411–421
22. Nakashima-Yasuda H, Uryu K, Robinson J et al (2007) Co-morbidity of TDP-43 proteinopathy in Lewy body related diseases. Acta Neuropathol 114:221–229
23. Nelson PT, Estus S, Abner EL et al (2014) ABCC9 gene polymorphism is associated with hippocampal sclerosis of aging pathology. Acta Neuropathol 127:825–843
24. Nelson PT, Schmitt FA, Lin Y et al (2011) Hippocampal sclerosis in advanced age: clinical and pathological features. Brain 134:1506–1518
25. Nelson PT, Smith CD, Abner EL et al (2013) Hippocampal sclerosis of aging, a prevalent and high-morbidity brain disease. Acta Neuropathol 126:161–177
26. Neumann M, Sampathu DM, Kwong LK et al (2006) Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science 314:130–133
27. Pao WC, Dickson DW, Crook JE, Finch NA, Rademakers R, Graff-Radford NR (2011) Hippocampal sclerosis in the elderly: genetic and pathologic findings, some mimicking Alzheimer disease clinically. Alzheimer Dis Assoc Disord 25:364–368
28. Rademakers R, Eriksen JL, Baker M et al (2008) Common variation in the miR-659 binding-site of GRN is a major risk factor for TDP43-positive frontotemporal dementia. Hum Mol Genet 17:3631–3642
29. Rutherford NJ, Carrasquillo MM, Li M et al (2012) TMEM106B risk variant is implicated in the pathologic presentation of Alzheimer disease. Neurology 79:717–718
30. Yokota O, Davidson Y, Arai T et al (2010) Effect of topographical distribution of alpha-synuclein pathology on TDP-43 accumulation in Lewy body disease. Acta Neuropathol 120:789–801
31. Zarow C, Sitzer TE, Chui HC (2008) Understanding hippocampal sclerosis in the elderly: epidemiology, characterization, and diagnostic issues. Curr Neurol Neurosci Rep 8:363–370
32. Zhang YJ, Xu YF, Cook C et al (2009) Aberrant cleavage of TDP-43 enhances aggregation and cellular toxicity. Proc Natl Acad Sci USA 106:7607–7612